HSV Rb p450
Latest Information Update: 30 May 2016
At a glance
- Originator MultiVir
- Class Gene therapies
- Mechanism of Action Gene transference; Tumour suppressor gene modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Colorectal cancer
Most Recent Events
- 30 May 2016 Phase-I development is ongoing in USA